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A B S T R A C T
Background: Cervical cancer is the most common gynecological cancer among women in Nigeria. The incidence is on the increase 
and poses a public health problem. The etiological agent is the human papilloma virus that is sexual transmitted. The cervical cancer 
incidence is related to lifestyle, poverty and sexual practices. Fortunately, it is a preventable disease as it is preceded by a pre-invasive 
phase that can be detected and treated. There is paucity of report in literature on cervical cancer screening in Sokoto North-West 
Nigeria. Aim: To determine the uptake, indications and results of cervical cancer screening in Usmanu Dan-fodiyo University Teaching 
Hospital (UDUTH), Sokoto. Materials and Methods: A 3-year descriptive study of the results of cervical cytology among women who 
attended the gynaecological out-patient clinic of UDUTH, Sokoto. Results: During the period of study, 126 cervical smears were taken 
and 96% (121/126) of them were considered adequate for cytological evaluation thus constituting the subjects of the study. The average 
annual uptake of cervical smear was 1.29%. The main indications for cytologic smears were abnormal uterine bleeding 33.9% (41/121) and 
suspected carcinoma of the cervix 28.1% (34/121). Cytologic study was positive for dysplastic cells in 7% (25/121) of cases. Ten percent 
(12/121) of them were high grade squamous intra-epithelial lesions while invasive carcinoma was seen in 3.3% (4/121) of the smears. 
Conclusion: Presence of abnormal cervical smear in 20% of the study subjects underscores the need for routine screening for cervical 
cancer. While organized national screening policy is awaited, opportunistic screening should be maximized.
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Cervical cancer is the most common genital tract malignancy 
worldwide.[1-5] About 200,000 to 300,000 deaths are 
recorded annually as a result of cervical cancer and 500,000 
new cases are diagnosed annually.[5,6] Most of the deaths 
occur in the developing countries where patients present 
with advanced stage of the disease and routine screening is 
either non-existent or limited.[6] In many centres in Nigeria, 
it is the second most common cancer (next to breast cancer) 
in women except in Kano where it is the leading female 
malignancy.[7,8] This is related to high prevalence of the risks 
factors (early sexual debut, poverty, high parity and multiple 
sexual partners) and limited availability/non-utilization of 
screening services which abound in Nigeria.[1,5,8]
In Sokoto, cervical cancer accounts for 61.5% of genital 
tract malignancies.[9] Interestingly, cervical cancer is largely 
a preventable disease.[1-9] It is preceded by a detectable 
and preventable pre-invasive phase of about a period of 
10-15 years.[1,6,8,10]
In 1941, Papanicolaou (Pap) described cervical mass 
screening for sexually active women for early detection 
of cervical cancer.[11] For many years, the conventional Pap 
smear has remained the common practice in cervical cancer 
screening.[1,10,11] In the developed countries, large scale 
screening programmes coupled with effective treatment 
of pre-invasive lesions have resulted in the decline in the 
incidence of invasive cervical cancer.[1-10] The reverse is the 
case in Nigeria where cervical cancer screening is mainly 
opportunistic.[10,12,13] Such opportunistic screening tends 
to reach groups at low risk, and miss those at high risk of 
developing the disease.[12,14] Presence of AIDS predisposes to 
cervical cancer by compromising immunological response 
to human papilloma viral infection.[15]
One of the limitations of Pap smear is that it only represents 
about 20% of the sample collected. This led to the 
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development of liquid-based cytology which collects the 
whole sample from the sampling device in liquid medium 
thus reducing the proportion of inadequate smears while 
increasing the chances of detecting true dyskaryosis.[16] 
Liquid-based cytology is now the standard test used by 
the National Health System of the United Kingdom for 
cervical cancer screening programme.[16] HIV infection 
is strongly implicated in the genesis of pre-invasive and 
invasive cancer of the cervix with 99.7% detection rate 
in cancer of the cervix.[17] Since identification of HPV 
in women with high grade squamous intra-epithelial 
lesion (HGSIL) and low grade squamous intra-epithelial 
lesions (LGSIL) is pointless as vast majority will be positive, 
most published data refer to HPV testing as an adjunct to 
cytology in women with borderline lesion.[16,18,19] There 
are two commercially available vaccines for of HPV, one 
a quadrivalent directed against HPV 6, 11, 16 and 18; and 
the second a bivalent directed against HPV 16 and 18. 
However, there are unanswered questions about these 
vaccines which include duration of their effects, when/how 
to administer booster doses and failure to protect against 
all the oncogenic HPV strains.[16]
This study is aimed at determining the uptake, indications 
and the results of cervical cytology in a tertiary health care 
centre in Sokoto, North-Western Nigeria.
MATERIALS AND METHODS
This is a descriptive study involving cervical smears 
that were assessed at the Histo-pathology department 
of Usmanu Dan-fodio University Teaching Hospital 
(UDUTH), Sokoto, over a 3-year period (1st January 2007 to 
31st December 2009).
The UDUTH, Sokoto, is a tertiary health institution located in 
the North-Western region of the country. The hospital has a 
residency programme in the sub-specialties like Obstetrics 
and Gynaecology, Surgery, Internal Medicine, public health, 
Histopathology, General Medicine. The hospital cases were 
referred from the health institutions in Sokoto metropolis 
and also from neighbouring states like Zamfara, Kebbi, and 
Niger states. It also obtains referrals from Niger republic, a 
country located in the northern frontiers of Nigeria.
The case notes of patients who had cervical cytology during 
the study period were retrieved from the medical records 
department. The records were traced to the Histopathology 
department where the cytology results were extracted 
and analyzed. Information obtained from the records 
included the patients’ demographic data such as age, place 
of residence, occupation parity; indications for cytology, 
specimen adequacy and cytological diagnosis were recorded 
in a study proforma.
All analysis was conducted using SPSS version 15.0 (Chicago Il, 
USA). Data were presented using relevant descriptive statistics 
such as percentages, means and standard deviations.
RESULTS
During the 3-year study period, 126 cervical smears were 
taken for screening, out of which 5 (3.97%), were inadequate 
for cytological evaluation according to the Bethesda 
Criteria.[16] The patients’ ages ranged from 20 years to 
65 years with a mean of 38.5 (2.9) years. The annual uptake of 
cervical cytology as shown in Table 1, revealed an increasing 
trend. The main indications for screening as shown in Table 2 
were abnormal uterine bleeding 41 (33.9%) and suspected 
cervical carcinoma 32 (26.5%). The Pap smear was only taken 
as a routine medical check-up in 26 subjects (21.5%). One of 
the subjects was pregnant. Cytologic smear was negative 
for abnormal cells in 69 cases (54.8%), while positive smears 
were present in 25 cases (19.8%). Invasive carcinoma was 
detected in 4 (3.2%) of the smears, while non-specific 
inflammatory lesions were seen in 17 (13.5%). Trichomonas 
vaginalis was present in 4% of the cases. Twelve (48%) of 
the positive smears were HGSIL (moderate and severe 
dysplasia), while the rest were LGSIL (mild dysplasia and 
changes due to HPV).
Table 3 shows the cytology result in relation to age.
HGSIL cytology was relatively common in the 30-49 years age 
group (10 out of 12), while LGSIL was more common in the 
30-39 years group (8 out of 13). Non-specific inflammatory 
lesions were predominant in the 20-24 years group, while 
invasive carcinoma was more prevalent in 50-69 year age 
group (3 out of 4). One patient, aged 25 years had invasive 
carcinoma.
Table 1: Annual uptake of cervical cytology
Year Total no. of patients  
registered in gynae. clinic
No. of cervical smears Annual %
2007 2902 34 1.2
2008 3071 37 1.2
2009 3375 50 1.5
Total 9348 121 1.3
Table 2: Indications for cervical smears
Indications for cytologic smear No. %
Abnormal uterine bleeding 41 33.9
Suspected cervical cancer 32 26.5
Routine medical check-up 26 21.5
Post-coital bleeding 5 4.1
Un-stated 6 5.0
Cervicitis 4 3.3
Post-menopausal bleeding 3 2.5
Chronic PID 3 2.5
Chronic vaginal discharge 1 0.8
Total 121 100
PID – Pelvic inflammatory disease
Journal of Basic and Clinical Reproductive Sciences · January - June 2013 · Vol 2 · Issue 120
Daniel, et al.: Cervical cytology, Sokoto
DISCUSSION
The average annual uptake of the Pap smear in this study 
(1.29%) is very low compared to other centres in Nigeria.[20,21] 
It may be due to ignorance and lack of awareness of the value 
of cervical cancer screening among the study population. 
However, awareness does not always translate to utilization 
as low utilization of cervical cytology services has been 
reported among health workers in the study population 
despite high level of awareness of the procedure.[13] Most of 
the indication for cervical cytology in this data was symptom 
based (79.4%). Routine cervical smear was performed in only 
20.6% of the subjects in this study compared to 53.8% in a 
similar study in Ibadan.[21] All these observations underscore 
the need for organized national screening programme.
Despite this poor uptake of the Pap smears, the relatively high 
rate of positive cytology (19.8%) in this study, calls for concern. 
This figure is higher than that reported in Enugu (12.2%)[10] 
and Ibadan (9.7%).[22] It also doubled the worldwide estimate 
of 10%.[19] Even more disturbing is the presence of HGSIL 
in almost 50% of the abnormal smears and squamous cell 
carcinoma in 3.2% of the total smears. This can be attributed to 
the high prevalence of risk factors to cervical cancer (poverty, 
early marriage, early age of sexual debut, high parity and 
multiple sexual partners) in the study population.[9] In a study 
in Kuwait, high grade lesions were seen in only 0.2% and 
invasive disease in 0.1% of the population.[23] The detection of 
an invasive carcinoma in a 25-year old woman in this study, 
highlights the need for screening to begin as early as possible, 
at most 3 years after the initiation of sexual activity.[10]
The abnormal Pap smears in the age-range from 30 years to 
45 years occurred in two-third of cases. It is not surprising 
because cervical cancer tends to be more prevalent within 
the age group of 50 years to 59 years in our centre.[9] 
Indeed it takes 10 years to 20 years for pre-invasive lesions 
to transform to malignant lesions.[1,6,8,10]
This study has demonstrated that pre-invasive lesions 
of cervical cancer are relatively common in the study 
population. However multi-centre study in the state 
involving a larger sample size will give better picture about 
the prevalent of the condition in state. The need for the 
formulation and implementation of organized national 
screening programme cannot be over-emphasized. In the 
interim, opportunistic screening should be maximized.
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